Trial Profile
Prevention of New Onset Diabetes After Transplantation by a Short Term Treatment of Vildagliptin in the Early Post-transplant Period
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Aug 2022
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- Acronyms PRODIG
- 01 Aug 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2024.
- 01 Aug 2022 Planned primary completion date changed from 1 Jul 2021 to 1 Jul 2024.
- 01 Feb 2021 Planned End Date changed from 1 Oct 2020 to 1 Dec 2021.